Over Expression of Dimethylarginine Dimethylaminohydrolase-1 (DDAH1) Slows Progression Fibrocalcific Aortic Valve Stenosis in Hypercholesterolemic Mice

被引：0
|
作者：
Zhang, Bin [1 ]
Oehler, Elise A. [1 ]
Roos, Carolyn M. [1 ]
Arghami, Arman [1 ]
Miller, Jordan D. [1 ,2 ]
机构：
[1] Mayo Clin, Div Cardiovasc Surg, Rochester, MN USA
[2] Mayo Clin, Dept Physiol, Rochester, MN USA
来源：
FASEB JOURNAL | 2012年 / 26卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页数：1
相关论文
共 48 条
  • [1] Dimethylarginine Dimethylaminohydrolase-1 Slows Progression of Fibrocalcific Aortic Valve Disease
    Zhang, Bin
    Oehler, Elise A.
    Roos, Carolyn M.
    Arghami, Arman
    Miller, Jordan D.
    CIRCULATION, 2011, 124 (21)
  • [2] Dimethylarginine Dimethylaminohydrolase-1 Slows Initiation of Fibrocalcific Aortic Valve Disease Independent of Nitric Oxide Bioavailability
    Zhang, B.
    Oehler, E. A.
    Roos, C. M.
    Arghami, A.
    Miller, J. D.
    CARDIOLOGY, 2012, 121 (02) : 145 - 145
  • [3] Cardiomyocyte dimethylarginine dimethylaminohydrolase-1 (DDAH1) plays an important role in attenuating ventricular hypertrophy and dysfunction
    Xu, Xin
    Zhang, Ping
    Kwak, Dongmin
    Fassett, John
    Yue, Wenhui
    Atzler, Dorothee
    Hu, Xinli
    Liu, Xiaohong
    Wang, Huan
    Lu, Zhongbing
    Guo, Haipeng
    Schwedhelm, Edzard
    Boeger, Rainer H.
    Chen, Peijie
    Chen, Yingjie
    BASIC RESEARCH IN CARDIOLOGY, 2017, 112 (05)
  • [4] Cardiomyocyte dimethylarginine dimethylaminohydrolase-1 (DDAH1) plays an important role in attenuating ventricular hypertrophy and dysfunction
    Xin Xu
    Ping Zhang
    Dongmin Kwak
    John Fassett
    Wenhui Yue
    Dorothee Atzler
    Xinli Hu
    Xiaohong Liu
    Huan Wang
    Zhongbing Lu
    Haipeng Guo
    Edzard Schwedhelm
    Rainer H. Böger
    Peijie Chen
    Yingjie Chen
    Basic Research in Cardiology, 2017, 112
  • [5] A role for Dimethylarginine Dimethylaminohydrolase 1 (DDAH1) in mammalian development
    Breckenridge, Ross A.
    Kelly, Peter
    Nandi, Manasi
    Vallance, Patrick J.
    Mohun, Timothy J.
    Leiper, James
    INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY, 2010, 54 (01): : 215 - 220
  • [6] Roles of dimethylarginine dimethylaminohydrolase 1 (DDAH1) in cerebral endothelial function and angiogenesis
    Flynn, Arun
    Riddell, Alexandra
    Dowsett, Laura
    Leiper, James
    Miller, Alyson
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2022, 42 (1_SUPPL): : 303 - 303
  • [7] Dimethylarginine dimethylaminohydrolase-1 (DDAH1) is frequently upregulated in prostate cancer, and its overexpression conveys tumor growth and angiogenesis by metabolizing asymmetric dimethylarginine (ADMA)
    Reddy, Karthik Kami
    Dasari, Chandrashekhar
    Duscharla, Divya
    Supriya, Bhukya
    Ram, N. Sai
    Surekha, M. V.
    Kumar, Jerald Mahesh
    Ummanni, Ramesh
    ANGIOGENESIS, 2018, 21 (01) : 79 - 94
  • [8] Dimethylarginine dimethylaminohydrolase-1 (DDAH1) is frequently upregulated in prostate cancer, and its overexpression conveys tumor growth and angiogenesis by metabolizing asymmetric dimethylarginine (ADMA)
    Karthik Reddy Kami Reddy
    Chandrashekhar Dasari
    Divya Duscharla
    Bhukya Supriya
    N. Sai Ram
    M. V. Surekha
    Jerald Mahesh Kumar
    Ramesh Ummanni
    Angiogenesis, 2018, 21 : 79 - 94
  • [9] Dimethylarginine dimethylaminohydrolase-1 (DDAH-1) inhibition by proton pump inhibitors: in vitro and in vivo significance
    Tommasi, S.
    Elliot, D. J.
    McEvoy, M.
    McElduff, P.
    Rowland, A.
    Hulin, J. -A.
    Lewis, B. C.
    Mangoni, A. A.
    EUROPEAN HEART JOURNAL, 2016, 37 : 306 - 307
  • [10] Dimethylarginine Dimethylaminohydrolase-1 Transgenic Mice Are Not Protected from Ischemic Stroke
    Leypoldt, Frank
    Choe, Chi-Un
    Gelderblom, Mathias
    von Leitner, Eike-Christin
    Atzler, Dorothee
    Schwedhelm, Edzard
    Gerloff, Christian
    Sydow, Karsten
    Boeger, Rainer H.
    Magnus, Tim
    PLOS ONE, 2009, 4 (10):
12345